Nostrum BioDiscovery, a new spin-off of the University of Barcelona, the IRB Barcelona, the BSC-CNS and the ICREA
This morning in Barcelona, the Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Supercomputing Center - National Supercomputing Center (BSC-CNS) have presented the spin-off Nostrum BioDiscovery, a new biotech company that applies computational simulation to help new drugs and biotech molecules to reach the market. The creation of this spin-off has also been made possible thanks to the Bosch i Gimpera Foundation of the University of Barcelona and the Catalan Institute for Research and Advanced Studies (ICREA).
This morning in Barcelona, the Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Supercomputing Center - National Supercomputing Center (BSC-CNS) have presented the spin-off Nostrum BioDiscovery, a new biotech company that applies computational simulation to help new drugs and biotech molecules to reach the market. The creation of this spin-off has also been made possible thanks to the Bosch i Gimpera Foundation of the University of Barcelona and the Catalan Institute for Research and Advanced Studies (ICREA).